Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
40 hedge funds and large institutions have $8.31M invested in Histogen Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
77% more call options, than puts
Call options by funds: $191K | Put options by funds: $108K
11% more funds holding
Funds holding: 36 → 40 (+4)
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $10.4M → $8.31M (-$2.04M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$244K |
| 2 |
CCM
Courage Capital Management
Nashville,
Tennessee
|
+$204K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$138K |
| 4 |
Renaissance Technologies
New York
|
+$128K |
| 5 |
D.E. Shaw & Co
New York
|
+$86.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$2.18M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$392K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$161K |
| 4 |
Citigroup
New York
|
-$37.9K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$22K |
HSTO Hedge Fund Activity: Q3 2016 in Review
40 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2016, worth a combined $8.31M — down 20% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new HSTO positions and 4 closed out — a net gain of 4 holders — while 11 added to existing stakes and 10 trimmed.
The largest buyer was Vanguard Group, adding an estimated $244K. The largest seller was HealthCor Management, exiting entirely with an estimated $2.18M sold.
- 40 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2016, up from 36 in Q2 2016.
- Funds reported $8.31M of Histogen Inc. Common Stock stock for Q3 2016, down 20% quarter-over-quarter.
- 8 funds opened new Histogen Inc. Common Stock positions in Q3 2016 and 4 closed out, a net change of +4 holders.
- The largest Histogen Inc. Common Stock buyer in Q3 2016 was Vanguard Group, an estimated $244K added.
- The largest Histogen Inc. Common Stock seller in Q3 2016 was HealthCor Management, an estimated $2.18M sold.
Based on aggregated 13F filings for Q3 2016.